Exam 1 Definitions and Concepts 1-4 Flashcards
pharmaceutics
- discipline of pharmacy that deals with the science of dosage form design and the process of turning a new chemical entity into a medication that can be safely and effectively used
- art and applied science
- interface between drug and body
pharmacodynamics
drug action and mechanism on the body
pharmacokinetics
body acting on the drug
absorption, distribution, metabolism, excretion
absorption
variety when people have health issues, oral vs. IV injection
distribution
benign cancer local vs malignant cancer being in many sites
metabolism
all food and drugs undergo it
*liver
*prodrugs
excretion
removal from body, may want to extend time
*kidney
chemical
a substance composed of chemical elements
drug
- substance recognzied by an official pharmacopoeia or formulary
- substance intended for the use in diagnosis, cure, mitigation, treatment, or prevention of disease
- intended to affect the structure or any function of the body
drug product
finished dosage form that contains a drug substance, generally, but not necessarily in association with other active or inactive ingredients
dosage form
physical form in which a drug is produced and dispensed
active ingredient
- component intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease
- affects the structure or any function of the body
- causes medication’s desired effect
inactive/inert ingredient
any component of a drug product other than active ingredient
*dyes, preservatives, and flavoring agents
brand drug
when the FDA approves a drug for the first time, there is only one manufacturer that makes and sells a drug
generic drug
produced after the brand name drug’s patent has expired, also must be approved by the FDA
over the counter drugs
can be dispensed without a prescription
prescription/legend drug
can only be dispensed with prescription from a licensed HCP
ex. estrogen
for: hormone replacement therapy for treatment of symptoms of menopause
molecules administered: conjugated estrogens, estradiol, estrone
dosage forms: tablets, transdermal patch, transdermal gel, vaginal ring
tablet
- compressed contains micronized estradiol
- micronization to improve dissolution
- may have high first pass effect
transdermal patch
- bypasses first-pass metabolism
vaginal ring
- topical application for local symptoms
dosage forms for safe and convenient delivery of accurate dosage
tablet, capsule syrup
dosage forms that protect a drug from chemical degradation, usually due to atmospheric oxygen or humidity (increase shelf life)
coated tablets, sealed ampoules
dosage forms that provide protection of drug form influence of gastric acid and saliva after oral administration
enteric coated tablets
dosage forms that mask taste of expensive drugs
capsules, coated tablets, flavored syrups
dosage forms that provide liquid preparation, even for drugs that are either insoluble or unstable
syrups, suspensions
dosage forms that provide injectable dosage forms with the correct composition (tonicity and pH) for compatibility with surrounding tissue
injections
*sterility and stability
dosage forms that provide slow or targeted release of drug
implants
dosage forms that provide optimal topical administration
creams, ointments, ophthalmic, ear, nasal
dosage forms that provide the optimal characteristics for the insertion of a drug into one of the body’s orifices
rectal and vaginal suppositories
dosage forms that provide the requirements for inhalation of drugs to the lung
inhalants
classes of pharmaceutical dosage forms, according to the overall physical properties of dosage froms
gaseous
liquid
semisolid
solid
gaseous dosage froms
medicinal gases
aerodispersions
medicinal gases
inhalation/volatile anesthetics (vaporized before admin by inhalation)
aerodispersions
solid particles or liquid particles
liquid dosage forms
solutions
emulsions
suspensions
solutions
prepared by dissolving one or more solutes in a solvent
*very small particle size
emulsions
a dispersion system consisting of 2 immiscible liquids
*oil in water or water in oil
suspensions
dispersion system where solid particles are dispersed in liquid phase
*larger particle size
*not intended for systemic admin of drugs with high potency
semi solids
gels
creams
ointments
pastes
*unshaped
gels
semisolid system in which a liquid phase is contained within a 3D cross-linked matrix
creams
semisolid emulsion systems (O/W, W/O), >10% of water
- O/W creams are more comfortable and cosmetically acceptable as they are less greasy and more water washable
- W/O creams accommodate and release better lipophilic API, moisturizing, cold creams
ointments
semisolid dosage forms with the oleaginous (hydrocarbon), water-soluble or emulsifying base
*oleaginous base- petrolatum (Vaseline)
*water soluble base- PEG
pastes
semisolid dispersion system, where solid particles are dispersed in ointments
*mostly oleaginous
shaped semi solids
suppositories (rectal)
*diff shapes
*melt/dissolve at body temp
*oleaginous (cacao butter, adeps neutralis) or aqueous (PEGs, glycerinated gelatine)
pessaries (vaginal)
*similar as above
*PEGs or glycerinated gelatine are often used as base
solid dosage forms
unshaped- powders
shaped- tablets, capsules, implants, transdermal patches
systemic admin
PO
sublingual and buccal
rectal
parenteral
transdermal
inhallation
local admin
topical on skin or mucosa (eye, nose, ear, mouth, vagina, rectum, bronchi, skin)
local pareneral
generations of dosage forms
1st gen- immediate release of API
2nd gen- controlled release of API (CR)
3rd gen- targeted distribution of drug delivery systems
1st gen dosage forms
- disintegration of dosage form and dissolution of API is spontaneous
- absorption and distribution is based only on physiochemical properties of API
2nd gen dosage forms
- release of API is under control of drug delivery system (temporal control)
- advantages: avoids fluctuations of plasma drug conc for safety and efficacy, decreased frequency of drug admin for better compliance, may overcome some problems with BAV, can be more economical
-SR- release of initial API and futher prolonged release
-CR- properly controlled release of API - pulsatile release- think diabetes devices
targeted drug delivery
drug delivery system provides altered PK profile, targeting drug to particular organ/tissue
*improved selectivity of action
*can overcome unfavorable PK properties
*improved efficacy
*improved tolerability/decreased toxicity
passive targeting
passive accumulation of drug at site of pathology due to the leaky vasculature and poor venous/lymphatic drainage, solid tumors draw more blood and may have larger pores
active targeting
drug delivery system with specific ligand with high affinity to receptor exposed selectively on the target cells
possible inert ingredients
anti-adherents
binders
coatings (change dissolution rates)
disintegrants
fillers/diluents
flavors and colors
glidants and lubricants (prevent aggregation)
preservatives
sorbents (so can be ok with some moisture)
sweeteners
cost to get one new medicine onto the market
$500-800 million
how many years to make a drug
12-15
how many out of 5,000 that enter preclinical testing make it to human testing
5
preclinical phase
research and development
clinical phase
also research and development, includes phases 1-3
postmarketing
surveillance, adverse reaction reporting, survey sampling, inspections
thermodynamics
describes the changes in the form of energy when a reaction occurs
*ex. converting chemical energy to heat
*will the reaction occur or not? feasible with stable product
*Ea (activation energy)
kinetics
describes the speed at which a reaction occurs
*rate and mechanism of action
*state functions (delta G, H, S,E)
first law of thermodynamics
energy is conserved, it can be neither created nor destroyed
second law
in an isolated system, natural processes are spontaneous when they lead to an increase in disorder, or entropy